BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37500565)

  • 1. White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study.
    Gan J; Shi Z; Liu S; Li X; Liu Y; Zhu H; Shen L; Zhang G; Lu H; Gang B; Chen Z; Ji Y
    Eur J Neurol; 2023 Dec; 30(12):3711-3721. PubMed ID: 37500565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China.
    Gan J; Chen Z; Shi Z; Li X; Liu S; Liu Y; Zhu H; Shen L; Zhang G; You Y; Guo Q; Zhang N; Lv Y; Gang B; Yuan J; Ji Y
    J Alzheimers Dis; 2022; 90(3):1263-1275. PubMed ID: 36245379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study.
    Gan J; Chen Z; Shi Z; Li X; Liu S; Liu Y; Zhu H; Shen L; Zhang G; You Y; Guo Q; Zhang N; Lv Y; Gang B; Yuan J; Ji Y
    Biol Sex Differ; 2022 Oct; 13(1):55. PubMed ID: 36183142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages.
    Chen TY; Chan PC; Tsai CF; Wei CY; Chiu PY
    Front Aging Neurosci; 2022; 14():935652. PubMed ID: 36092817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
    Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
    Jellinger KA
    Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias.
    Ciafone J; Little B; Thomas AJ; Gallagher P
    J Int Neuropsychol Soc; 2020 Feb; 26(2):210-225. PubMed ID: 31826772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in patients with ParkinsonĀ“s disease and the analysis of associated factors.
    Kobak Tur E; Ari BC
    Neurol Res; 2023 Dec; 45(12):1161-1168. PubMed ID: 37743634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies.
    Liu C; Liu S; Wang X; Ji Y
    Aging Ment Health; 2021 Nov; 25(11):2011-2017. PubMed ID: 32896168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Jul; 130(7):891-904. PubMed ID: 37306790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    Gan J; Chen Z; Liu S; Shi Z; Liu Y; Wang XD; Liu C; Ji Y
    BMC Neurol; 2022 Sep; 22(1):355. PubMed ID: 36123648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.